Blog – How We Ensure Safety in Dementia Drug Trials
Emma Law explains how safety is protected in dementia drug trials, from recruitment & screening to monitoring participants throughout complex clinical studies
Dr Emma Law is Strategic Manager for the The Neuroprogressive and Dementia Network in Scotland. Emma has 13 years experience as a Clinical Trails Network Manager and over 35 years experience as a Nurse, many of which were spent in the delivery of Clinical Research Trials. Emma completed her PhD and is passionate about giving people living with dementia and their carers access to participate in research.
Emma Law explains how safety is protected in dementia drug trials, from recruitment & screening to monitoring participants throughout complex clinical studies
Dr Emma Law weighs the promise of AI voice agents against the human touch of clinicians in dementia trials using the Cognitive Dementia Rating Scale.
Dr Emma Law explores challenges & best practices in recruiting participants for clinical trials, highlighting strategies to improve success in dementia research
Some people say no to taking part in research. Dr Emma Law explores why, and shares ways we can respond with respect and understanding.
Dr Emma Law explores the hallmarks of a strong clinical research team—clear roles, open communication, shared responsibility, and a sense of humour.
Dr Emma Law reflects on key lessons from her first clinical trial, highlighting challenges, organisation, and best practices. Read more.
Dr Emma Law, a clinical trials expert with over 35 years of experience, shares insights into the complexities and realities faced by clinical trial raters.